If your booking diary or social feeds have felt busier than usual with enquiries about a so-called “freezing facial,” you are not imagining it. Polynucleotide treatments have become one of the most talked-about categories in aesthetics this year, and much of that conversation is now centred on VITARAN, Fox Pharmacy’s polynucleotide-based skin booster line. For practitioners, understanding why this trend has taken hold is the first step to deciding whether it belongs on your treatment menu.
What Is Driving the Viral Interest?
Much of the current buzz has come from patients sharing their experiences online, drawn to the idea of a treatment that works with the skin’s own repair processes rather than simply adding volume. The phrase “freezing ageing” is, of course, marketing shorthand rather than a literal claim — no treatment can stop the ageing process. What seems to resonate with clients is the concept of supporting skin quality and resilience from within, which polynucleotide-based products are designed to do. Interest has also been fuelled by practitioners posting before-and-after content, patient testimonials, and general education about the category, which has helped normalise the conversation around biorevitalisation treatments among a wider audience.
The Science Behind Polynucleotides
Polynucleotides are fragments of DNA, typically derived and purified for cosmetic and medical use, that are formulated into injectable gels. They are thought to work by supporting the skin’s natural regenerative processes, including hydration, tissue repair signalling, and antioxidant activity within the dermis. Clinical studies suggest polynucleotide-based treatments may help improve skin tone, elasticity, and overall texture over a course of sessions, though results vary between individuals and should never be presented as guaranteed or permanent. As with any biostimulatory treatment, outcomes depend on factors such as skin condition, lifestyle, and how consistently a patient follows a recommended treatment plan.
Why Practitioners Are Adding VITARAN to Their Menus
For clinics, the appeal of VITARAN lies in offering patients a treatment option that sits comfortably alongside more established biorevitalisation and skin booster protocols. It is designed to be used as part of a broader skin health strategy, often alongside good skincare habits and other in-clinic treatments, rather than as a standalone miracle fix. Practitioners considering VITARAN should ensure they are appropriately trained in polynucleotide administration and that they understand the product’s intended use, patient suitability criteria, and any contraindications before offering it to clients.
Managing Client Expectations
With viral trends comes the risk of inflated expectations. Patients arriving with phrases like “freezing facial” in mind may need a clear, honest conversation about what polynucleotide treatments can realistically offer. It is worth explaining that this is a supportive, cumulative approach to skin quality rather than an instant transformation, and that individual results will differ. Being transparent about this from the consultation stage helps build trust and supports responsible, ethical practice — something that matters more than ever as aesthetic treatments continue to attract mainstream attention.
If you would like to learn more about how VITARAN fits into a modern polynucleotide treatment offering, browse the range on the Fox Pharmacy website or get in touch with our team, who are happy to talk through product information and training resources for qualified practitioners.
